Oxytocin-Gly-Lys-Arg stimulates cardiomyogenesis by targeting cardiac side population cells

Bogdan A Danalache1, Calvin Yu, Jolanta Gutkowska

  • 1Research Centre, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada Department of Medicine, Université de Montréal, Montreal, Quebec, Canada.

Insights

Oxytocin (OT) stimulates cardiac stem cell differentiation. This study shows OT-Gly-Lys-Arg (OT-GKR) promotes cardiac side population (SP) CD31- cells to become contracting cardiomyocytes, aiding heart growth.

Area of Science:

  • Cardiovascular Biology
  • Developmental Biology
  • Stem Cell Research

Background:

  • The oxytocin (OT) system is functional in the heart.
  • OT promotes cardiac stem cell (CSC) differentiation into cardiomyocytes (CM).
  • Cardiac side population (SP) cells are a CSC population.

Purpose of the Study:

  • Investigate oxytocin receptors (OTR) in cardiac SP cells.
  • Determine if OT-Gly-Lys-Arg (OT-GKR) induces cardiac differentiation in SP cells.
  • Explore OT-GKR's role in fetal rodent heart development.

Main Methods:

  • Immunocytochemistry on E11 rat embryos to detect OTR and SP markers.
  • Flow cytometry to quantify OTR expression on SP cells.
  • In vitro culture of SP cells with OT-GKR to assess proliferation and differentiation.

Main Results:

  • OTR and brcp1 (SP marker) were co-localized in the embryonic rat heart.
  • OTR was expressed on SP cells, particularly CD29+ and CD31+ subpopulations.
  • OT-GKR treatment induced proliferation and cardiac differentiation of SP CD31- cells into CM.
  • OT-GKR also promoted an endothelial phenotype in SP cells.

Conclusions:

  • The C-terminally extended oxytocin molecule (OT-GKR) stimulates cardiac differentiation of SP CD31- cells.
  • OT-GKR plays a role in heart growth and development.
  • OTR signaling in cardiac SP cells is a potential target for cardiac regeneration.

Related Concept Videos

Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
2.0K
Structure of Cardiac Muscles01:13

Structure of Cardiac Muscles

Cardiac muscle, or myocardium, is a specialized type of muscle found exclusively in the heart. Its unique structural and functional characteristics enable the heart to perform its vital role of pumping blood throughout the body continuously and rhythmically. The cardiac muscle cells, or cardiomyocytes, possess an endomysium and perimysium but do not have an epimysium.
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...
16.8K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
952